The New Kid On The Block: What’s Delta-8?

In recent years, Delta-8, which is short for delta-8-tetrahydrocannabinol, is a hemp-derived chemical substance that has gained wide popularity in the cannabis world. This is mainly due to the plethora of benefits it offers and the milder high it produces compared to the intoxicating delta-9. What is delta-8 and how does it compare to delta-9?… Continue reading The New Kid On The Block: What’s Delta-8?

How to prepare outdoor hemp and marijuana fields for growing season

(This is the first of a series focused on planning for best cultivation practices for hemp and marijuana growers. Look for additional stories on handling young plants, stocking up on supplies, fertigation and other topics throughout the year.) Outdoor hemp and marijuana growers are getting ready to get their crops in the ground in the… Continue reading How to prepare outdoor hemp and marijuana fields for growing season

Canadian biotech firm forms JV with Australis Capital to expand capabilities in U.S.

An expanding tissue-culture laboratory with locations in Washington and Canada has entered into a joint venture with Australis Capital, a U.S. spinoff of Canadian marijuana producer Aurora Cannabis. 3 Rivers Biotech Inc., an agricultural technology company that specializes in commercial-scale micropropagation for marijuana, hemp and traditional crops including vegetables and fruit, will own 85% of… Continue reading Canadian biotech firm forms JV with Australis Capital to expand capabilities in U.S.

Minor cannabinoids are a ‘new frontier’ in wellness: Q&A with Jonathan Vaught, CEO of Front Range Biosciences

Minor cannabinoids have been gathering interest among growers and extractors over the past year, with research on CBG, CBN, CBC and THC-V showing unique health benefits for consumers. But are consumers even aware of these molecules and is there demand in the marketplace? And are there genetics available that can yield enough of these minor… Continue reading Minor cannabinoids are a ‘new frontier’ in wellness: Q&A with Jonathan Vaught, CEO of Front Range Biosciences